Vennila Ponnusamy1,2,3, Olga Kapellou4, Ellen Yip1, Jane Evanson5, Liang-Fong Wong6, Adina Michael-Titus7, Ping K Yip7, Divyen K Shah1,2. 1. Center of Paediatrics, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. 2. Neonatal Unit, The Royal London Hospital, Barts Health NHS Trust, London, UK. 3. Neonatal Intensive Care Unit, Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK. 4. Neonatal Intensive Care Unit, Homerton University Hospitals NHS Foundation Trust, London, UK. 5. Imaging Services, The Royal London Hospital, Barts Health NHS Trust, London, UK. 6. School of Clinical Sciences, University of Bristol, Bristol, UK. 7. Center of Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Abstract
BACKGROUND: The potential of microRNAs (miRNAs) as bedside biomarkers in selecting newborns with hypoxic-ischemic encephalopathy (HIE) for neuroprotection has yet to be explored. Commonly, blood-based biomarker tests use plasma or serum which don't allow evaluation of both intracellular and extracellular changes. METHODS: We describe a technique to extract and compare expression of miRNAs from a single small 6-mm-diameter dried blood spot (DBS) stored at room temperature with those from EDTA-blood, plasma, and urine. Three miRNAs (RNU6B, let7b, and miR-21) were quantified via extraction and quantitative RT-PCR performed from a DBS and compared with levels from EDTA-blood, plasma, and urine. Secondarily, candidate miRNAs let7b, miR-21, miR-29b, miR-124, and miR-155 in DBS were evaluated as potential biomarkers for HIE. RESULTS: Candidate miRNAs were extractable in all biosamples from newborns, with the highest expression in DBS. There was a good correlation between miRNAs' levels in DBS and EDTA-blood at -80 °C. No significant difference was observed in the miRNA levels between the favorable and unfavorable outcome groups for babies with HIE. CONCLUSION: DBS may be useful for studying the potential of miRNAs as biomarkers for brain injury.
BACKGROUND: The potential of microRNAs (miRNAs) as bedside biomarkers in selecting newborns with hypoxic-ischemic encephalopathy (HIE) for neuroprotection has yet to be explored. Commonly, blood-based biomarker tests use plasma or serum which don't allow evaluation of both intracellular and extracellular changes. METHODS: We describe a technique to extract and compare expression of miRNAs from a single small 6-mm-diameter dried blood spot (DBS) stored at room temperature with those from EDTA-blood, plasma, and urine. Three miRNAs (RNU6B, let7b, and miR-21) were quantified via extraction and quantitative RT-PCR performed from a DBS and compared with levels from EDTA-blood, plasma, and urine. Secondarily, candidate miRNAs let7b, miR-21, miR-29b, miR-124, and miR-155 in DBS were evaluated as potential biomarkers for HIE. RESULTS: Candidate miRNAs were extractable in all biosamples from newborns, with the highest expression in DBS. There was a good correlation between miRNAs' levels in DBS and EDTA-blood at -80 °C. No significant difference was observed in the miRNA levels between the favorable and unfavorable outcome groups for babies with HIE. CONCLUSION: DBS may be useful for studying the potential of miRNAs as biomarkers for brain injury.
Authors: Diego Gazzolo; Raul Abella; Emanuela Marinoni; Romolo di Iorio; Giovanni Li Volti; Fabio Galvano; Alessandro Frigiola; Francesca Temporini; Luca Moresco; Micaela Colivicchi; Miriam Sabatini; Alberto Ricotti; Maria Chiara Strozzi; Sandro Crivelli; Francesco Maria Risso; Andrea Sannia; Pasquale Florio Journal: J Matern Fetal Neonatal Med Date: 2009
Authors: Jennifer S McDonald; Dragana Milosevic; Honey V Reddi; Stefan K Grebe; Alicia Algeciras-Schimnich Journal: Clin Chem Date: 2011-04-12 Impact factor: 8.327
Authors: Sabrina M Lehmann; Christina Krüger; Boyoun Park; Katja Derkow; Karen Rosenberger; Jan Baumgart; Thorsten Trimbuch; Gina Eom; Michael Hinz; David Kaul; Piet Habbel; Roland Kälin; Eleonora Franzoni; Agnieszka Rybak; Duong Nguyen; Rüdiger Veh; Olaf Ninnemann; Oliver Peters; Robert Nitsch; Frank L Heppner; Douglas Golenbock; Eckart Schott; Hidde L Ploegh; F Gregory Wulczyn; Seija Lehnardt Journal: Nat Neurosci Date: 2012-06 Impact factor: 24.884
Authors: Lorenzo F Sempere; Sarah Freemantle; Ian Pitha-Rowe; Eric Moss; Ethan Dmitrovsky; Victor Ambros Journal: Genome Biol Date: 2004-02-16 Impact factor: 13.583
Authors: Mary J Reust; Myung Hee Lee; Jenny Xiang; Wei Zhang; Dong Xu; Tatiana Batson; Tuo Zhang; Jennifer A Downs; Kathryn M Dupnik Journal: Am J Trop Med Hyg Date: 2018-03-01 Impact factor: 2.345
Authors: Maria L V Dizon; Raye-Ann O deRegnier; Steven J Weiner; Michael W Varner; Dwight J Rouse; Maged M Costantine; Ronald J Wapner; John M Thorp; Sean C Blackwell; Nina K Ayala; Antonio F Saad; Steve N Caritis Journal: Dev Neurosci Date: 2022-06-15 Impact factor: 3.421
Authors: Gary P Brennan; Dimitrios M Vitsios; Sophie Casey; Ann-Marie Looney; Boubou Hallberg; David C Henshall; Geraldine B Boylan; Deirdre M Murray; Catherine Mooney Journal: PLoS One Date: 2018-12-03 Impact factor: 3.240
Authors: Dana Boyd Barr; Naveen Puttaswamy; Lindsay M Jaacks; Kyle Steenland; Sarah Rajkumar; Savannah Gupton; P Barry Ryan; Kalpana Balakrishnan; Jennifer L Peel; William Checkley; Thomas Clasen; Maggie L Clark Journal: Environ Health Perspect Date: 2020-04-29 Impact factor: 9.031
Authors: Vennila Ponnusamy; Richard T H Ip; Moumin A E K Mohamed; Paul Clarke; Eva Wozniak; Charles Mein; Leslie Schwendimann; Akif Barlas; Philippa Chisholm; Ela Chakkarapani; Adina T Michael-Titus; Pierre Gressens; Ping K Yip; Divyen K Shah Journal: Commun Biol Date: 2021-09-30
Authors: Jill Chang; Robert H Lurie; Abhineet Sharma; Mirrah Bashir; Camille M Fung; Robert W Dettman; Maria L V Dizon Journal: eNeuro Date: 2021-06-07